Is Ventana's resistance wearing thin as Roche chips away at its defences?
This article was originally published in Clinica
Executive Summary
Despite increasing pressure from Roche's $3bn hostile takeover, Ventana Medical Systems remains defiant that it can resist an attempted buyout.